I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Exit Strategies in Natalizumab-Treated RRMS at High Risk of..:
Zanghi A
;
Gallo A
;
Avolio C
...
info:eu-repo/semantics/altIdentifier/wos/WOS:000639643100002. , 2021
Link:
http://hdl.handle.net/11573/1553118
RT Journal T1 <Title>Exit Strategies in Natalizumab-Treated RRMS at High Risk of Progressive Multifocal Leukoencephalopathy: a Multicentre Comparison Study</Title> UL https://suche.suub.uni-bremen.de/peid=base-ftunivromairis:oai:iris.uniroma1.it:11573_1553118&Exemplar=1&LAN=DE A1 Zanghi A A1 Gallo A A1 Avolio C A1 Capuano R A1 Lucchini M A1 Petracca M A1 Bonavita S A1 Lanzillo R A1 Ferraro D A1 Curti E A1 Buccafusca M A1 Callari G A1 Barone S A1 Pontillo G A1 Abbadessa G A1 Di Francescantonio V A1 Signoriello E A1 Lus G A1 Sola P A1 Granella F A1 Valentino P A1 Mirabella M A1 Patti F A1 D'Amico E PB Springer Science and Business Media Deutschland GmbH YR 2021 K1 Cladribine K1 Disease activity K1 Exit strategy K1 Natalizumab K1 Ocrelizumab K1 Rituximab JF info:eu-repo/semantics/altIdentifier/wos/WOS:000639643100002 LK http://hdl.handle.net/11573/1553118 DO http://hdl.handle.net/11573/1553118 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)
